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Autoimmune pancreatitis is a unique type of chronic pancreatitis, which is rarely associated with pseudocyst. A
48-year-old lady was admitted to our department with a rapidly growing cystic mass in the pancreatic tail with an
elevated concentration of serum carbohydrate antigen 19-9 (CA19-9). She had a history of autoimmune pancreatitis
and received steroid treatment. Imaging studies demonstrated a cystic mass in the pancreatic tail. The mass kept
growing despite restoration of steroid treatment. Eventually, the patient underwent distal pancreatectomy
with splenectomy. Histopathological examination revealed the existence of pseudocyst, significant lymphocytic
infiltration, and fibrotic change in the pancreatic tail.
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Autoimmune pancreatitis is a peculiar uniform of chronic
pancreatitis. The International Association of Pancreatology
presented a set of diagnostic criteria for autoimmune pan-
creatitis [1]. Like other types of pancreatitis, autoimmune
pancreatitis can be complicated with pseudocyst, although
this is rarely reported [2-4]. Kawakami et al. [2] suggested
that corticosteroid treatment should be started immediately
when a pseudocyst appears, accompanying autoimmune
pancreatitis, because the pseudocyst did disappear with
treatment. However, there is no consensus on therapeutic
strategy for autoimmune pancreatitis associated with
pseudocyst without good response to steroid treatment.
Here, we present a patient who was clinically diagnosed
with autoimmune pancreatitis with a rapidly growing cys-
tic mass located in the pancreatic tail that was insensitive
to steroid therapy. This patient underwent distal pancrea-
tectomy with splenectomy.* Correspondence: shusenzheng@zju.edu.cn
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A 48-year-old lady was referred to our department for a
rapidly growing cystic mass in the pancreatic tail with
elevated concentrations of serum carbohydrate antigen
19-9 (CA19–9) (71 u/l), which was found during follow-
up for autoimmune pancreatitis. She had no history of
smoking or drinking. She had initially presented with jaun-
dice 7 months ago. Autoimmune pancreatitis was diag-
nosed based on her presentation, elevated serum IgG4
(165 mg/dl) level and image findings (Figure 1A). There-
fore, prednisone therapy was started at 30 mg/d and ta-
pered by 5 mg every week. The patient’s jaundice gradually
vanished. After that, she came to our department periodic-
ally for follow-up. A cystic mass of size 3 cm × 2 cm×
2 cm in her pancreatic tail was found 2 months ago, by
magnetic resonance imaging (MRI) (Figure 1B). Serum
and urine amylase levels were not elevated. The concentra-
tion of serum CA19-9 was 53u/l. Taking this information
in combination with her history, we diagnosed auto-
immune pancreatitis complicated with a pseudocyst.
Conservative management was adopted. The patient re-
stored prednisone therapy with 30 mg/d, tapering by
5 mg every week. The patient’s condition was fine with-
out any symptoms or signs. However, 2 months later,
she started to feel abdominal distension, especially afterThis is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
Figure 1 Diagnostic magnetic resonance imaging (MRI) and computed tomography (CT). (A) (MRI) diffuse enlargement of pancreas
(arrowhead), (B) (MRI) cystic mass in tail of pancreas (arrowhead), (C) (CT) obviously enlarged cystic mass in tail of pancreas (arrowhead), (D) (CT)
varices of gastric body (arrowhead), (E) (CT) thrombosis in splenic vein (arrowhead).
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cyst had enlarged to 4 cm × 3 cm × 3 cm (Figure 1C), as-
sociated with varices in the partial gastric fundus and
body in close proximity to the pancreatic tail (Figure 1D)
and thrombosis in splenic vein (Figure 1E).
On hospital admission, the patient continued to take
prednisone 5 mg/d. Pertinent laboratory data revealed
that serum and urine amylase levels were within normal
ranges, as were transaminase and serum bilirubin levels.
However, levels of serum CA19-9 (71 u/l) and serum
IgG4 (173 mg/dl) were still beyond the upper limit of
normal and higher than 2 months previously. Endoscopic
retrograde cholangiopancreatography and endoscopic
ultrasonography were refused by the patient.
Owing to suspicion of cystic neoplasm, drainage of the
lesion was not adopted. The patient underwent distal pan-
createctomy with splenectomy. The postoperative course
was uneventful and the patient was discharged after 7 days.
The postoperative serum concentration of CA19-9 de-
creased to 23 u/l. Histopathological examination revealed
a pseudocyst, significant lymphoplasmatic infiltration andfibrosis in the tail of the pancreas (Figure 2), but IgG4
immunostaining was negative.
Discussion
Cyst formation in autoimmune pancreatitis may be asso-
ciated with a highly active state of the inflammatory
process [3] and severe narrowing of the branched pan-
creatic ducts [4]. Steroids are thought to induce pseudo-
cyst regression through inhibition of inflammation of the
pancreatic duct, thus reducing the stenosis and improving
the drainage of pancreatic juice [5]. Hirano et al. reported
that a growing pancreatic pseudocyst developed in a pa-
tient with autoimmune pancreatitis who did not receive
corticosteroid treatment [6]. Kawakami et al. [2] have
advised corticosteroid treatment if a pseudocyst appears,
accompanying autoimmune pancreatitis. However, there
was no consensus in therapeutic strategy for autoimmune
pancreatitis associated with pseudocyst insensitive to ster-
oid treatment. For those cases with ineffective corticoster-
oid treatment, increasing hormone dosage might be an
option, but dosage and duration cannot be determined,
Figure 2 Histological sections stained by H & E from the resected pancreatic specimen. (A) Pseudocyst wall without evidence of epithelial
lining (horizontal arrow), significant lymphoplasmatic infiltration (vertical arrow) or fibrosis (arrowhead) (original magnification 100×). (B) Significant
lymphoplasmatic infiltration (arrow) (original magnification 400×).
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complications.
Operation can be another option in the case of inef-
fective conservative management. Takita et al. [7] pre-
sented a patient who was clinically diagnosed with
autoimmune pancreatitis accompanied with pseudocyst,
was resistant to steroid therapy, and underwent total
pancreatectomy with islet autotransplantation. Here, we
present the first case of autoimmune pancreatitis with a
pancreatic pseudocyst without good response to steroid
therapy treated by partial pancreatectomy with splenec-
tomy. In this case, the cystic lesion in the tail of the pan-
creas was found during follow-up after steroid treatment.
The size of the cystic lesion and serum CA19-9 concentra-
tion continued to increase despite restoration of steroids.
For poor response to steroids of the cystic mass, and the
suspicion of cystic neoplasm and thrombosis in the splenic
vein, distal pancreatectomy with splenectomy was chosen
for this patient.
During postoperative follow-up, serum concentrations
of CA19-9 and IgG4 returned to normal, and the patient
did not take prednisone or other treatments, but further
long-term follow-up is still necessary in case of recur-
rence of autoimmune pancreatitis or pseudocyst.
Conclusion
We believe that partial pancreatectomy with sple-
nectomy is another alternative therapy for pseudocyst
found in autoimmune pancreatitis when the cyst is in-
sensitive to prednisone treatment, and is accompanied
with suspicion of neoplasm and thrombosis in splenic
vein.
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